Patient info

M05BB Bisphosphonates, combinations affecting bone structure and mineralization

ATC group of level 4 – chemical subgroup · in plain English: medicines for osteoporosis and other bone diseases

This site has the patient leaflet or the SPC of 6 medicines in this group and its subgroups.

Place in the ATC classification

  1. M Musculo-skeletal system drugs 701 medicines
    1. M05 Drugs for treatment of bone diseases 135 medicines
      1. M05B Drugs affecting bone structure and mineralization 135 medicines
        1. M05BB Bisphosphonates, combinations affecting bone structure and mineralization 6 medicines
          1. M05BB03 alendronic acid and colecalciferol 6 medicines

8 more subgroups have no medicine with a leaflet on this site.

Active substances in the group

Medicines in the group and its subgroups

MedicineLegal category
Adrovance SPC (M05BB03 alendronic acid and colecalciferol) –
Alendronic Acid/cholecalciferol tablet 70 mg/2800 IU SPC (M05BB03 alendronic acid and colecalciferol) –
Bentexo 70 mg / 5 600 IU tablets SPC no longer supplied (M05BB03 alendronic acid and colecalciferol) –
Fosavance 70 mg/2 800 IU tablet (M05BB03 alendronic acid and colecalciferol) Prescription only (POM)
Fosavance 70 mg/5 600 IU tablet SPC (M05BB03 alendronic acid and colecalciferol) Prescription only (POM)
Vantavo (previously Alendronate sodium and colecalciferol, MSD) SPC (M05BB03 alendronic acid and colecalciferol) –

Other groups of the same level

Other names of the ATC group

Sources

  • Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
  • Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
  • World Health Organization (WHO): ATC/DDD classification, group M05BB

Contains public sector information licensed under the Open Government Licence v3.0.

Ask your doctor or pharmacist which medicine is right for you.